rs104894735
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001272071.2(AP1S2):c.154C>T(p.Arg52*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001272071.2 stop_gained
Scores
Clinical Significance
Conservation
Publications
- syndromic X-linked intellectual disability 5Inheritance: XL Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
- X-linked syndromic intellectual disabilityInheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
- fried syndromeInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
- autism spectrum disorderInheritance: XL Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| AP1S2 | NM_001272071.2 | c.154C>T | p.Arg52* | stop_gained | Exon 2 of 6 | ENST00000672987.1 | NP_001259000.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| AP1S2 | ENST00000672987.1 | c.154C>T | p.Arg52* | stop_gained | Exon 2 of 6 | NM_001272071.2 | ENSP00000500695.1 |
Frequencies
GnomAD3 genomes Cov.: 24
GnomAD4 exome Cov.: 29
GnomAD4 genome Cov.: 24
ClinVar
Submissions by phenotype
Pettigrew syndrome Pathogenic:3
The hemizygous, maternally inherited c.154C>T (p.Arg52Ter) variant identified in the AP1S2 gene leads to the premature termination of the protein at amino acid 52/161 (coding exon 2/6). This variant is absent from gnomAD and ExAC, suggesting it is not a common benign variant in the populations represented in these databases. This variant is reported in ClinVar as Pathogenic (VarID: 10778), and has been reported in two families in the literature with AP1S2 related X-Linked Intellectual Disability Syndrome [PMID: 17186471; PMID: 18428203]. Given its deleterious nature, absence in population databases, and observation in multiple affected indiviudals in the literature, the c.154C>T (p.Arg52Ter) variant identified in the AP1S2 gene is reported here as Pathogenic. -
The stop gained c.154C>T(p.Arg52Ter) variant in AP1S2 gene has been reported in hemizygous state in individuals affected with AP1S2 related disorder (Tarpey PS, et. al., 2006; Borck G, et. al., 2008). The c.154C>T variant is absent in gnomAD Exomes. This variant has been submitted to the ClinVar database as Pathogenic (multiple submissions). Computational evidence (MutationTaster - Disease causing) predict damaging effect on protein structure and function for this variant. The nucleotide change c.154C>T in AP1S2 is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. This variant is predicted to cause loss of normal protein function through protein truncation. Loss of function variants have been previously reported to be disease causing (Tarpey PS, et. al., 2006). For these reasons, this variant has been classified as Pathogenic -
- -
not provided Pathogenic:1
Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 19377476, 25525159, 17186471) -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at